Cardiovascular autonomic function in Cushing's syndrome

Journal of Endocrinological Investigation

Volumn 32, Issue 1, 2009, Pages 41-45

  Fallo, Francesco ^a   Maffei, P ^a   Dalla Pozza, A ^a   Carli, M ^a   Della Mea, P ^a   Lupia, M ^a   Rabbia, F ^b   Sonino, N ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Autonomic function; Cushing's syndrome; Heart

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEART RATE VARIABILITY; HUMAN; HYDROCORTISONE RELEASE; HYPERTENSION; MALE; OBESITY; PARASYMPATHETIC FUNCTION; VAGUS NERVE STIMULATION;

EID: 64549120266     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345677     Document Type: Article

References (40)

1. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996, 93: 1043-65.
2. Tsuji H, Larson MG, Venditti FJ Jr, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996, 94: 2850-5.
3. Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Correlations among time and frequency domain measures of heart rate variability two weeks after myocardial infarction. Am J Cardiol 1992, 69: 891-8.
4. Nolan J, Flapan AD, Goodfiels NE, et al. Measurement of parasympathetic activity from-24-hour ambulatory electrocardiograms and its reproducibility and sensitivity in normal subjects, patients with symptomatic myocardial ischemia, and patients with diabetes mellitus. Am J Cardiol 1996, 77: 154-8.
5. Kohara K, Hara-Nakamura N, Hiwada K. Left ventricular mass index negatively correlates with heart rate variability in essential hypertension. Am J Hypertens 1995, 8: 183-8.
6. Burger AJ, Charlamb M, Sherman HB. Circadian patterns of heart rate variability in normals, chronic stable angina and diabetes mellitus. Int J Cardiol 1999, 71: 41-8.
7. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension: Systolic Hypertension in Europe Trial Investigators. JAMA 1999, 282: 539-46.
8. Kikuya M, Hozawa A, Ohokuloo T, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000, 36: 901-6.
9. Metoki H, Ohkubo T, Kikuya M, et al. Prognostic significance for stroke of a morning pressure surge and a nocturnal blood pressure decline: the Ohasama Study. Hypertension 2006, 47: 149-54.
10. Parati G. Blood pressure variability: its measurement and significance in hypertension. J Hypertens 2005, 23: S19-25.
11. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994, 24: 793-801.
12. Cuspidi C, Macca G, Sampieri L, et al. Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens 2001, 19: 1539-45.
13. Whitworth JA, Schyvens CG, Zhang Y, Mangos GJ, Kelly JJ. Glucocorticoid-induced hypertension: from mouse to man. Clin Exp Pharmacol Physiol 2001, 28: 993-996.
14. Walker BR. Glucocorticoids and cardiovascular disease. Eur J Endocrinol 2007, 157: 545-59.
15. Lindholm J, Juul S, Jørgensen JOL, et al. Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 2001, 86: 117-23.
16. Pivonello R, Faggiano A, Lombardi G, Colao A. The metabolic syndrome and the cardiovascular risk in Cushing's syndrome. Endocrinol Metab Clin N Am 2005, 34: 327-39.
17. Imai Y, Abe K, Sasaki S, et al. Altered circadian blood pressure rhythm in patients with Cushing's syndrome. Hypertension 1988, 12: 11-9.
18. Zelinka T, Strauch B, Pecen L, Widimsky J. Diurnal blood pressure variation in phechromocytoma, primary aldosteronism and Cushing's syndrome. J Hum Hypertens 2004, 18: 107-11.
19. Fallo F, Budano S, Sonino N, Muiesan ML, Agabiti-Rosei E, Boscaro M. Left ventricular structural characteristics in Cushing's syndrome. J Hum Hypertens 1994, 8: 509-13.
20. Muiesan ML, Lupia M, Salvetti M, et al. Left ventricular structural and functional characteristics in Cushing's syndrome. J Am Coll Cardiol 2003, 41: 2275-9.
21. Boscaro M, Barzon L, Fallo F, Sonino N. Cushing's sindrome. Lancet 2001, 357: 783-91.
22. Fallo F, Paoletta A, Tona F, Boscaro M, Sonino N. Response of hypertension to conventional antihypertensive treatment and/or steroidogenesis inhibitors in Cushing's sindrome. J Intern Med 1993, 234: 595-8.
23. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 1988, 2: 397.
24. Della Mea P, Lupia M, Bandolin V, et al. Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients. Am J Hypertens 2005, 18: 30-5.
25. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58: 1072-83.
26. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodelling in arterial hypertension. J Am Coll Cardiol 1992, 19: 1550-8.
27. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment on left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57: 450-8.
28. de Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and of the impact of overweight. J Am Coll Cardiol 1992, 20: 1251-60.
29. Palatini P, Longo D, Zaetta V, Perkovic D, Garbelotto R, Pessina AC. Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity. J Hypertens 2006, 24: 1375-81.
30. Ziegler D, Zentai C, Perz S, et al; KORA Study Group. Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes 2006, 114: 153-9.
31. Rabbia F, Silke B, Conterno A, et al. Assesment of cardiac autonomic modulation during adolescent obesity. Obes Res 2003, 11: 541-8.
32. Whitworth JA, Mangos GJ, Kelly JJ. Cushing, cortisol, and cardiovascular disease. Hypertension 2000, 36: 912-6.
33. Nonell A, Bodenseh S, Lederebogen F, et al. Chronic but not acute hydrocortisone treatment shifts the response to an orthostatic challenge towards parasympathetic activity. Neuroendocrinology 2005, 81: 63-8.
34. Bellavere F, Balzani I, De Masi G, et al. Power spectral analysis of heart rate variations improves the assessment of diabetic cardiac autonomic neuropathy. Diabetes 1992, 41: 633-40.
35. Resmini E, Casu M, Patrone V, et al. Sympathovagal imbalance in acromegalic patients. J Clin Endocrinol Metab 2006, 91: 115-20.
36. Galetta F, Franzoni F, Fallahi P, et al. Changes in heart rate variability and QT dispersion in patients with overt hypothyroidism. Eur J Endocrinol 2008, 158: 85-90.
37. Kohara K, Nishida W, Maguchi M, Hiwada K. Autonomic nervous function in non-dipper essential hypertensive subjects. Evaluation by power spectral analysis of heart rate variability. Hypertension 1995, 26: 808-14.
38. Fouad FM, Tarazi RC, Ferrario CM, Fighaly S, Alicandri C. Assessment of parasympathetic control of heart rate by a noninvasive method. Am J Physiol 1984, 246 (pt 2): H838-42.
39. Alter P, Grimm W, Vollrath A, Czerny F, Maisch B. Heart rate variability in patients with cardiac hypertrophy-relation to left ventricular mass and etiology. Am Heart J 2006, 151: 829-36.
40. Mureddu GF, de Simone G, Greco R, Rosato GF, Contaldo F. Left ventricular filling in arterial hypertension. Influence of obesity and hemodynamic and structural confounders. Hypertension 1997, 29: 544-50.